Combination of Pharmacophore Matching, 2D Similarity Search, and In Vitro Biological Assays in the Selection of Potential 5‐HT6 Antagonists from Large Commercial Repositories. (30th April 2015)
- Record Type:
- Journal Article
- Title:
- Combination of Pharmacophore Matching, 2D Similarity Search, and In Vitro Biological Assays in the Selection of Potential 5‐HT6 Antagonists from Large Commercial Repositories. (30th April 2015)
- Main Title:
- Combination of Pharmacophore Matching, 2D Similarity Search, and In Vitro Biological Assays in the Selection of Potential 5‐HT6 Antagonists from Large Commercial Repositories
- Authors:
- Dobi, Krisztina
Flachner, Beáta
Pukáncsik, Mária
Máthé, Enikő
Bognár, Melinda
Szaszkó, Mária
Magyar, Csaba
Hajdú, István
Lőrincz, Zsolt
Simon, István
Fülöp, Ferenc
Cseh, Sándor
Dormán, György - Abstract:
- <abstract abstract-type="main" id="cbdd12563-abs-0001"> <title> <x xml:space="preserve">Abstract</x> </title> <p>Rapid <italic>in silico</italic> selection of target‐focused libraries from commercial repositories is an attractive and cost‐effective approach. If structures of active compounds are available, rapid 2D similarity search can be performed on multimillion compound databases, but the generated library requires further focusing. We report here a combination of the 2D approach with pharmacophore matching which was used for selecting 5‐HT<sub>6</sub> antagonists. In the first screening round, 12 compounds showed >85% antagonist efficacy of the 91 screened. For the second‐round (hit validation) screening phase, pharmacophore models were built, applied, and compared with the routine 2D similarity search. Three pharmacophore models were created based on the structure of the reference compounds and the first‐round hit compounds. The pharmacophore search resulted in a high hit rate (40%) and led to novel chemotypes, while 2D similarity search had slightly better hit rate (51%), but lacking the novelty. To demonstrate the power of the virtual screening cascade, ligand efficiency indices were also calculated and their steady improvement was confirmed.</p> </abstract>
- Is Part Of:
- Chemical biology & drug design. Volume 86:Number 4(2015:Oct.)
- Journal:
- Chemical biology & drug design
- Issue:
- Volume 86:Number 4(2015:Oct.)
- Issue Display:
- Volume 86, Issue 4 (2015)
- Year:
- 2015
- Volume:
- 86
- Issue:
- 4
- Issue Sort Value:
- 2015-0086-0004-0000
- Page Start:
- 864
- Page End:
- 880
- Publication Date:
- 2015-04-30
- Subjects:
- Drugs -- Design -- Periodicals
Pharmaceutical chemistry -- Periodicals
Biochemistry -- Periodicals
615.19005 - Journal URLs:
- http://gateway.ovid.com/ovidweb.cgi?T=JS&MODE=ovid&NEWS=n&PAGE=toc&D=ovft&AN=01253034-000000000-00000 ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1747-0285 ↗
http://www.blackwell-synergy.com/loi/jpp ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/cbdd.12563 ↗
- Languages:
- English
- ISSNs:
- 1747-0277
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3139.120000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 3539.xml